Blue Owl Capital Corporation III to Begin Trading on New York Stock Exchange

Rhea-AI Summary

Blue Owl Capital Corporation III (OBDE) has received approval from the New York Stock Exchange and is expected to commence trading under the ticker symbol 'OBDE'. Preliminary Q4 2023 estimates show a net investment income per share range of $0.56 to $0.59 and a net asset value per share range of $15.52 to $15.58. Full financial results for Q4 and year ended December 31, 2023, will be released on February 21, 2024.

Insights

Financial Analyst

The preliminary financial results for Blue Owl Capital Corporation III, particularly the Net Investment Income (NII) and Net Asset Value (NAV) per share, are key indicators of the company's financial health and performance. The reported NII range shows stability from the previous quarter, which suggests consistent earnings from the company's investments. The slight increase in NAV per share indicates potential growth in the company's assets or a reduction in liabilities. Investors would view this as a positive sign of asset appreciation or effective debt management.

Such financial metrics are critical for assessing the company's ability to generate income and manage its asset portfolio effectively. An increasing NAV per share could make the company's stock more attractive to investors, potentially leading to a higher stock price once trading commences under the new ticker symbol 'OBDE'. However, it's important to consider the broader market conditions and industry performance when evaluating these results.

Market Research Analyst

The initiation of trading under a new ticker symbol often garners investor attention and can influence stock performance due to heightened visibility. The role of lead advisors and co-advisors, including major players like BofA Securities and J.P. Morgan, suggests a strong support network for the listing, which could instill confidence among investors and positively impact the stock's initial trading period.

Furthermore, the timing of the release of full financial results shortly after the commencement of trading could play a significant role in the stock's early performance. Investors will be watching closely and robust full-year results could further validate the preliminary Q4 figures, potentially leading to increased investor interest and positive stock momentum.

Legal Expert

The involvement of a reputable legal advisor, Eversheds Sutherland (US) LLP, in the listing process for Blue Owl Capital Corporation III is a testament to the company's commitment to compliance and due diligence. This legal backing is crucial for ensuring that all regulatory requirements are met for the NYSE listing, which in turn can affect investor confidence and the company's reputation.

Legal advisement is also essential for navigating the complex regulatory environment associated with financial reporting and securities trading. The presence of a competent legal team can mitigate risks associated with non-compliance, which could have adverse financial implications and impact investor trust.

Announces Preliminary Q4 2023 Financial Results

NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Blue Owl Capital Corporation III (NYSE: OBDE or the "Company"), a leading business development company ("BDC") focused on lending to U.S. upper middle-market companies, has received approval from the New York Stock Exchange ("NYSE") and is expected to commence trading tomorrow, January 25, 2024, under the ticker symbol "OBDE."

Preliminary Estimates of Fourth Quarter Results

For the quarter ended December 31, 2023, the Company estimates a net investment income ("NII") per share range of $0.56 to $0.59, compared to $0.56 for the quarter ended September 30, 2023. The Company also estimates a net asset value ("NAV") per share range of $15.52 to $15.58 as of December 31, 2023, compared to $15.40 as of September 30, 2023.

		Estimates for the three months ended and as of
		December 31, 2023*
NII per Share		$0.56 – $0.59
NAV per Share		$15.52 – $15.58

The Company expects to release full financial results for the fourth quarter and year ended December 31, 2023 on Wednesday, February 21, 2024 after market close. In addition to the press release, OBDE will distribute a shareholder letter the following day.

Advisors

BofA Securities, J.P. Morgan, RBC Capital Markets, Goldman Sachs & Co. LLC, MUFG, SMBC Nikko Securities America, Inc., and Truist Securities are serving as lead advisors to the Company in connection with the listing. Compass Point Research & Trading, LLC, Deutsche Bank Securities Inc., ING, JMP Securities, A Citizens Company, Keefe, Bruyette & Woods, Inc., KeyBanc Capital Markets, Morgan Stanley & Co. LLC, Natixis, Oppenheimer & Co. Inc., R. Seelaus & Co., LLC, Raymond James, Scotiabank, Societe Generale, and Wells Fargo Securities are also acting as co-advisors. Eversheds Sutherland (US) LLP acted as legal advisor to the Company.

ABOUT BLUE OWL CAPITAL CORPORATION III

Blue Owl Capital Corporation III (NYSE: OBDE) is a specialty finance company focused on lending to U.S. upper middle-market companies. As of September 30, 2023, OBDE had investments in 146 portfolio companies with an aggregate fair value of $3.6 billion. OBDE has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. OBDE is externally managed by Blue Owl Diversified Credit Advisors, an SEC-registered investment adviser that is an indirect affiliate of Blue Owl Capital Inc. ("Blue Owl") (NYSE: OWL) and is a part of Blue Owl's Credit platform.

* Company estimates for NII per share are calculated using 122,682,216 weighted average shares for the three months ended December 31, 2023. NAV per share estimates are calculated using 122,817,625 shares as of December 31, 2023.

The preliminary financial estimates provided herein have been prepared by, and are the responsibility of, the Company's management. Neither KPMG LLP, the Company's independent registered public accounting firm, nor any other independent accountants, have audited, reviewed, compiled, or performed any procedures with respect to the accompanying preliminary financial data.

These estimates are subject to the completion of the Company's financial closing procedures, as well as the determination of the fair value of the Company's investments as of December 31, 2023, and are not a comprehensive statement of the Company's financial results as of December 31, 2023. Actual results may differ materially from these estimates as a result of the completion of the period and the Company's financial closing procedures, final adjustments and other developments which may arise between now and the time that the Company's financial results are finalized.

Certain information contained herein may constitute "forward-looking statements" that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about OBDE, its current and prospective portfolio investments, its industry, its beliefs and opinions, and its assumptions. Words such as "anticipates," "expects," "intends," "plans," "will," "may," "continue," "believes," "seeks," "estimates," "would," "could," "should," "targets," "projects," "outlook," "potential," "predicts" and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond OBDE's control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements including, without limitation, the risks, uncertainties and other factors identified in OBDE's filings with the SEC. Investors should not place undue reliance on these forward-looking statements, which apply only as of the date on which OBDE makes them. OBDE does not undertake any obligation to update or revise any forward-looking statements or any other information contained herein, except as required by applicable law.

INVESTOR CONTACTS

Investor Contact:
Dana Sclafani
212-419-3000
credit-ir@blueowl.com

Media Contact:
Prosek Partners
Josh Clarkson
pro-blueowl@prosek.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/blue-owl-capital-corporation-iii-to-begin-trading-on-new-york-stock-exchange-302043233.html

SOURCE Blue Owl Capital Corporation III

FAQ

What is the ticker symbol for Blue Owl Capital Corporation III?

The ticker symbol for Blue Owl Capital Corporation III is 'OBDE'.

When will Blue Owl Capital Corporation III commence trading under its new ticker symbol?

Blue Owl Capital Corporation III is expected to commence trading under the ticker symbol 'OBDE' on January 25, 2024.

What are the preliminary estimates for the net investment income (NII) per share for Q4 2023?

The preliminary estimates for the net investment income (NII) per share range from $0.56 to $0.59 for the quarter ended December 31, 2023.

What are the preliminary estimates for the net asset value (NAV) per share for Q4 2023?

The preliminary estimates for the net asset value (NAV) per share range from $15.52 to $15.58 as of December 31, 2023.

When will the full financial results for Q4 and year ended December 31, 2023 be released?

The full financial results for the fourth quarter and year ended December 31, 2023, will be released on February 21, 2024, after market close.